Voiding Dysfunction 

  • Author: Christopher S Cooper, MD, FACS, FAAP; Chief Editor: Marc Cendron, MD   more...
 
Updated: Mar 5, 2010
 

Background

Voiding dysfunction is a common problem in children and accounts for as many as 40% of pediatric urology clinic visits. The challenge for the clinician is to differentiate a pathologic pattern of urgency or incontinence due to an underlying urologic abnormality from benign conditions related to incomplete or abnormal toilet training. Normal voiding frequency in children (after attainment of bladder control or age 5 y) is defined as 4-7 voids per day. Voiding symptoms (eg, urgency, frequency, incontinence) reflect alterations in urinary bladder function. The pathogenesis of voiding disorders is best understood and managed when considered as deviations from the normal voiding cycle consisting of bladder filling with urine storage followed by bladder emptying with voiding.

Infants regularly void by detrusor (bladder muscle) contraction as much as hourly, with small voided volumes and incomplete bladder emptying. With increasing age, bladder function matures and bladder capacity increases. Children aged 2-5 years have increased awareness of bladder fullness and develop the ability to volitionally void or inhibit voiding until it is socially acceptable. During this period, acquisition of cortical control of micturition occurs. Many forms of voiding dysfunction can be thought of as a delay in the acquisition of daytime urinary control, which typically occurs by age 4 years.

Daytime wetting is considered a problem in developmentally normal children aged 4 years or older who are wet several days each week and in previously continent children who develop daytime wetting.

Persistent daytime urinary incontinence may have an underlying neurologic, anatomic, infectious, or functional basis. This article focuses on daytime voiding disorders in children without neurologic, anatomic, obstructive, or infectious abnormalities of the urinary tract; however, any child with evidence of neurological dysfunction (eg, cutaneous signs, physical examination findings, severely refractory voiding dysfunction, urodynamic evidence of neurogenic bladder) should be further evaluated for occult neurologic lesions. Isolated nocturnal enuresis, which may be considered a form of voiding disorder, is considered elsewhere and is not reviewed here.

Next

Pathophysiology

The micturition cycle involves 2 discrete processes: (1) bladder filling and storage of urine and (2) bladder emptying with voiding. These functions are cyclic in nature.

During the filling phase of micturition, regulatory influence of the sympathetic nervous system allows the bladder to expand at low pressure. Urine storage is a coordinated response of the sympathetic-mediated inhibition of detrusor contractile activity. The primary neurotransmitter for sympathetic activity is norepinephrine.

Expulsion of urine normally occurs as a result of simultaneous voiding contraction of the detrusor muscle and relaxation of the bladder outlet (urethra, bladder neck, and pelvic floor muscles). This is mediated by the parasympathetic nervous system, in which the primary neurotransmitter is acetylcholine. During bladder filling, afferent impulses are transmitted to sensory neurons in the dorsal root ganglia of sacral spinal segments 2-4 and convey information to the brainstem. Nerve impulses from the brainstem during bladder filling inhibit parasympathetic outflow from the sacral spinal micturition center. During the voiding phase, inhibition of the sacral parasympathetic outflow is removed, and detrusor contraction occurs. Somatic impulses traveling along the pudendal nerve act to relax the muscle of the external sphincter. The result is expulsion of urine with minimal outlet resistance.

CNS control over the lower urinary tract coordinates the micturition cycle. Normal development is characterized by increasing awareness of bladder distension and acquisition of the ability to inhibit voiding. Voiding symptoms in the neurologically and anatomically intact child, who has neither a urinary tract infection (UTI) nor local urethral irritation, is a result of functional disturbance of the normal micturition cycle.

Previous
Next

Epidemiology

Frequency

United States

A study of 583 children aged 5-9 years showed that urinary urgency and pelvic-tightening maneuvers to postpone voiding and prevent leakage were the most common voiding problems.[1] Urge incontinence was reported in 7% of girls and in 3% of boys.

Daytime wetting has been reported to decrease with age. The prevalence of daytime wetting with a frequency of at least once every 2 weeks was 10% in children aged 5-6 years, 5% in children aged 6-12 years, and 4% in children aged 12-18 years.[2]

International

A large 2009 study from Australia addressed the frequency of voiding disorders in school-aged children.[3] This study of 2,856 students reported that 17% of children had experienced daytime incontinence in the previous 6 months. There was not a strong correlation between frequency and number of incontinence episodes. Independent risk factors for daytime incontinence included nocturnal enuresis, female sex, history of UTI, and encopresis.

Mortality/Morbidity

A child with a voiding disorder may have few symptoms or frequent urinary tract problems. Children with functional voiding disorders may have ongoing urge incontinence, urinary dribbling, or recurrent UTIs. These children may experience severe social and emotional problems because of the voiding disorder.

A few children with a functional voiding disorder (ie, nonneurogenic neurogenic bladder [Hinman-Allen syndrome]), have marked dysfunctional voiding and may incur significant renal damage.

Race

No known studies have shown the incidence of voiding disorders related to race.

Sex

Studies on the prevalence of voiding disorders in school children indicate that daytime urinary incontinence is 2-5 times more common in girls.[3]

Age

A functional voiding disorder in a neurologically and anatomically healthy child is not usually recognized before the acquisition of daytime urinary control.

Many children have a transient period of urinary urgency, occasionally with wetting accidents, when daytime continence is first being achieved. Most of these children develop normal urinary control in a relatively short period; however, some children may have persistence of urinary urgency and wetting.

Other children may have a normal voiding pattern until a UTI or an emotionally traumatic event triggers the onset of voiding symptoms.

Previous
 
 
Contributor Information and Disclosures
Author

Christopher S Cooper, MD, FACS, FAAP  Professor of Urology, Director of Pediatric Urology, University of Iowa, Children's Hospital of Iowa; Associate Dean for Student Affairs and Curriculum, University of Iowa Carver College of Medicine

Christopher S Cooper, MD, FACS, FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, American Medical Association, American Urological Association, International Children's Continence Society, Phi Beta Kappa, Society for Basic Urologic Research, Society for Fetal Urology, and Society for Pediatric Urology

Disclosure: Nothing to disclose.

Coauthor(s)

Kenneth G Nepple, MD  Resident Physician, Department of Urology, University of Iowa Hospitals and Clinics

Kenneth G Nepple, MD is a member of the following medical societies: Alpha Omega Alpha and American Urological Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Bartley G Cilento, Jr, MD  Instructor, Department of Surgery, Division of Urology, Children's Hospital of Boston and Harvard Medical School

Bartley G Cilento, Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Urological Association, and Massachusetts Medical Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine

Disclosure: Nothing to disclose.

Harry P Koo, MD  Chairman of Urology Division and Director of Pediatric Urology, Virginia Commonwealth University; Professor of Surgery, VCU School of Medicine, Medical College of Virginia; Director of Urology, Children's Hospital of Richmond

Harry P Koo, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Surgeons, and American Urological Association

Disclosure: Nothing to disclose.

Daniel Rauch, MD, FAAP  Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine

Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine

Disclosure: Baxter Honoraria Consulting

Chief Editor

Marc Cendron, MD  Associate Professor of Surgery, Harvard School of Medicine; Consulting Staff, Department of Urological Surgery, Children's Hospital Boston

Marc Cendron, MD is a member of the following medical societies: American Academy of Pediatrics, American Urological Association, European Society for Paediatric Urology, Johns Hopkins Medical and Surgical Association, New Hampshire Medical Society, Society for Fetal Urology, and Society for Pediatric Urology

Disclosure: Nothing to disclose.

References
  1. Hellerstein S, Zguta AA. Outcome of overactive bladder in children. Clin Pediatr (Phila). Jul-Aug 2003;42(6):553-6. [Medline].

  2. Bloom DA, Seeley WW, Ritchey ML, McGuire EJ. Toilet habits and continence in children: an opportunity sampling in search of normal parameters. J Urol. May 1993;149(5):1087-90. [Medline].

  3. Sureshkumar P, Jones M, Cumming R, Craig J. A population based study of 2,856 school-age children with urinary incontinence. J Urol. Feb 2009;181(2):808-15; discussion 815-6. [Medline].

  4. Neveus T, von Gontard A, Hoebeke P, Hjalmas K, Bauer S, Bower W. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol. Jul 2006;176(1):314-24. [Medline].

  5. Chandra M, Saharia R, Shi Q, Hill V. Giggle incontinence in children: a manifestation of detrusor instability. J Urol. Nov 2002;168(5):2184-7; discussion 2187. [Medline].

  6. Allen HA, Austin JC, Boyt MA, Hawtrey CE, Cooper CS. Initial trial of timed voiding is warranted for all children with daytime incontinence. Urology. May 2007;69(5):962-5. [Medline].

  7. Ellsworth PI, Merguerian PA, Copening ME. Sexual abuse: another causative factor in dysfunctional voiding. J Urol. Mar 1995;153(3 Pt 1):773-6. [Medline].

  8. Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics. Aug 1997;100(2 Pt 1):228-32. [Medline].

  9. Erickson BA, Austin JC, Cooper CS, Boyt MA. Polyethylene glycol 3350 for constipation in children with dysfunctional elimination. J Urol. Oct 2003;170(4 Pt 2):1518-20. [Medline].

  10. Sher PK, Reinberg Y. Successful treatment of giggle incontinence with methylphenidate. J Urol. Aug 1996;156(2 Pt 2):656-8. [Medline].

  11. Glazier DB, Ankem MK, Ferlise V, Gazi M, Barone JG. Utility of biofeedback for the daytime syndrome of urinary frequency and urgency of childhood. Urology. Apr 2001;57(4):791-3; discussion 793-4. [Medline].

  12. Sureshkumar P, Bower W, Craig JC, Knight JF. Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials. J Urol. Jul 2003;170(1):196-200; discussion 200. [Medline].

  13. Van Arendonk KJ, Austin JC, Boyt MA, Cooper CS. Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder. Urology. May 2006;67(5):1049-53; discussion 1053-4. [Medline].

  14. Van Arendonk KJ, Knudson MJ, Austin JC, Cooper CS. Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin. Urology. Oct 2006;68(4):862-5. [Medline].

  15. Youdim K, Kogan BA. Preliminary study of the safety and efficacy of extended-release oxybutynin in children. Urology. Mar 2002;59(3):428-32. [Medline].

  16. Kramer SA, Rathbun SR, Elkins D, Karnes RJ, Husmann DA. Double-blind placebo controlled study of alpha-adrenergic receptor antagonists (doxazosin) for treatment of voiding dysfunction in the pediatric population. J Urol. Jun 2005;173(6):2121-4; discussion 2124. [Medline].

  17. Ollendick TH, King NJ, Frary RB. Fears in children and adolescents: reliability and generalizability across gender, age and nationality. Behav Res Ther. 1989;27(1):19-26. [Medline].

  18. Schulman SL, Quinn CK, Plachter N, Kodman-Jones C. Comprehensive management of dysfunctional voiding. Pediatrics. Mar 1999;103(3):E31. [Medline].

  19. Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol. Sep 1998;160(3 Pt 2):1019-22. [Medline].

  20. Hoebeke P, Van Laecke E, Van Camp C, Raes A, Van De Walle J. One thousand video-urodynamic studies in children with non-neurogenic bladder sphincter dysfunction. BJU Int. Apr 2001;87(6):575-80. [Medline].

  21. Wald E. Urinary tract infections in infants and children: a comprehensive overview. Curr Opin Pediatr. Feb 2004;16(1):85-8. [Medline].

  22. Fitzgerald MP, Thom DH, Wassel-Fyr C, Subak L, Brubaker L, Van Den Eeden SK. Childhood urinary symptoms predict adult overactive bladder symptoms. J Urol. Mar 2006;175(3 Pt 1):989-93. [Medline].

  23. Bower WF, Yip SK, Yeung CK. Dysfunctional elimination symptoms in childhood and adulthood. J Urol. Oct 2005;174(4 Pt 2):1623-7; discussion 1627-8. [Medline].

  24. Bower WF, Sit FK, Yeung CK. Nocturnal enuresis in adolescents and adults is associated with childhood elimination symptoms. J Urol. Oct 2006;176(4 Pt 2):1771-5. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.